- authorisedTherapeutic confirmatory (Phase III)
Evaluate the superiority of Treatment with RAvulizumab vs plasma exchange during the first episode or a relapse In acute neuromyelitis optica (NMO) patients: a national, multicentric, randomised trial
This study looks at a new way to treat sudden flare-ups or first attacks of neuromyelitis optica (NMO). Researchers want to see if an antibody medicine called ravulizumab works better than plasma exchange (filtering the blood) to help people recover their vision and movement over a two-month period.
France - recruitingNA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
This study is testing a new smartphone app, NMOSDCopilot, for people with Neuromyelitis Optica (NMOSD). The app helps you check your symptoms at home. We want to see if it's accurate and easy to use compared to tests done at a clinic.
United States · France · Germany